Vimarsana
Biggest News Aggregation in the World

Abivax News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Abivax. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Abivax Today - Breaking & Trending Today

What the World Malaria Report says about India - Vimarsana News

What the World Malaria Report says about India

Bucking global trends, Malaria cases and deaths have continued to decline in India. What is behind India’s success story? How does climate change play a part? Why is there a need for improved surveillance? And what are the challenges ahead?

Abivax announces the resumption of its liquidity contract - Vimarsana News

Abivax announces the resumption of its liquidity contract

Abivax announces the resumption of its liquidity contract Paris, France, November 21, 2023 – 8:30 a.m. CET – Abivax SA (Euronext Paris and Nasdaq: ABVX)...

Abivax Adds $236M to Show Its Anti-Inflammatory Med Can Stand Apart in Crowded Field - Vimarsana News

Abivax Adds $236M to Show Its Anti-Inflammatory Med Can Stand Apart in Crowded Field

Abivax pulled off stock market deals in the U.S. and Europe that infuse the biotech with capital to continue clinical development of a small molecule for inflammation that’s differentiated from biologic therapies. In other biotech IPO news, Cargo Therapeutics and Invea Therapeutics both filed paperwork to go public.

PR News | On the Move: Krispy Kreme Appoints Daukus VP-IR - Vimarsana News

PR News | On the Move: Krispy Kreme Appoints Daukus VP-IR

Krispy Kreme appoints Stephanie Daukus as VP of investor relations.

Abivax receives Capital Market Transaction of the Year Award at the European Mediscience Awards 2023 - Vimarsana News

Abivax receives Capital Market Transaction of the Year Award at the European Mediscience Awards 2023

The award recognizes a significant capital market transaction in the biotech sectorAbivax received the award for its oversubscribed EUR 130M cross-over financing at market price with top-tier US and European